IL-23 activity in inflammation is associated with a unique gene signature that includes IL17A, IL23A, CCL20, and IL1R1. These gene expressions were notably increased in the livers of patients with advanced NAFLD. The gene discussed is IL37; the disease is metabolic dysfunction-associated steatotic liver disease.